Dual Metabolomic Platforms Identified a Novel Urinary Metabolite Signature for Hepatitis B Virus-Infected Patients with Depression.

Jing XieChang ChenLi-Juan HouChan-Juan ZhouLiang FangJian-Jun Chen

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)

These results suggested that the dual metabolomic platforms could yield a better urinary biomarker panel for dHB subjects than any single metabolomic platform did, and our results could be helpful for developing an objective method in future to diagnose depression in HBV-infected patients.

Keyphrases

hepatitis b virus
liver failure
depressive symptoms
sleep quality
high throughput
current status
single cell